IL139297A0 - Imidazo pyridine derivatives which inhibit gastric acid secretion - Google Patents

Imidazo pyridine derivatives which inhibit gastric acid secretion

Info

Publication number
IL139297A0
IL139297A0 IL13929799A IL13929799A IL139297A0 IL 139297 A0 IL139297 A0 IL 139297A0 IL 13929799 A IL13929799 A IL 13929799A IL 13929799 A IL13929799 A IL 13929799A IL 139297 A0 IL139297 A0 IL 139297A0
Authority
IL
Israel
Prior art keywords
gastric acid
acid secretion
pyridine derivatives
inhibit gastric
imidazo pyridine
Prior art date
Application number
IL13929799A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL139297A0 publication Critical patent/IL139297A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13929799A 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion IL139297A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000663 WO1999055706A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (1)

Publication Number Publication Date
IL139297A0 true IL139297A0 (en) 2001-11-25

Family

ID=20411154

Family Applications (4)

Application Number Title Priority Date Filing Date
IL13929799A IL139297A0 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion
IL13920099A IL139200A0 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion
IL139200A IL139200A (en) 1998-04-29 2000-10-23 GASTRIC ACID SECRETION INHIBITING (N - SUBSTITUTED) IMIDAZO [1,2 - a] PYRIDINE - 6 - CARBOXAMIDES CARRYING A BENZYL GROUP IN POSITION 8, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME INTERMEDIATES THEREFOR
IL139297A IL139297A (en) 1998-04-29 2000-10-26 Derivatives of imidazo pyridine that inhibit gastric acid secretion

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL13920099A IL139200A0 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion
IL139200A IL139200A (en) 1998-04-29 2000-10-23 GASTRIC ACID SECRETION INHIBITING (N - SUBSTITUTED) IMIDAZO [1,2 - a] PYRIDINE - 6 - CARBOXAMIDES CARRYING A BENZYL GROUP IN POSITION 8, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME INTERMEDIATES THEREFOR
IL139297A IL139297A (en) 1998-04-29 2000-10-26 Derivatives of imidazo pyridine that inhibit gastric acid secretion

Country Status (33)

Country Link
US (2) US6313136B1 (cs)
EP (4) EP1491542B1 (cs)
JP (2) JP3692034B2 (cs)
KR (3) KR100650472B1 (cs)
CN (2) CN1174980C (cs)
AR (2) AR015768A1 (cs)
AT (4) ATE312101T1 (cs)
AU (2) AU769108B2 (cs)
BR (2) BR9909995B1 (cs)
CA (2) CA2329921A1 (cs)
CZ (2) CZ292567B6 (cs)
DE (4) DE69927803T2 (cs)
DK (2) DK1073657T3 (cs)
EE (2) EE04676B1 (cs)
ES (2) ES2252975T3 (cs)
HU (2) HUP0102313A3 (cs)
ID (2) ID27530A (cs)
IL (4) IL139297A0 (cs)
IS (2) IS5683A (cs)
MY (2) MY121389A (cs)
NO (2) NO318203B1 (cs)
NZ (2) NZ507638A (cs)
PL (2) PL343797A1 (cs)
RU (2) RU2238271C2 (cs)
SA (2) SA99200064B1 (cs)
SE (1) SE9801526D0 (cs)
SI (1) SI1073656T1 (cs)
SK (2) SK285768B6 (cs)
TR (4) TR200102612T2 (cs)
TW (2) TWI250159B (cs)
UA (2) UA66846C2 (cs)
WO (2) WO1999055705A1 (cs)
ZA (2) ZA200005796B (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
ATE324871T1 (de) * 2001-02-13 2006-06-15 Astrazeneca Ab Neue formulierung mit modifizierter freisetzung
EE05234B1 (et) * 2001-03-08 2009-12-15 Astrazeneca Ab 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
TWI351405B (en) 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
RS20050377A (en) 2002-11-19 2007-11-15 Altana Pharma Ag., 8-substituted imidazopyridines
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
ES2502490T3 (es) 2003-02-26 2014-10-03 Sugen, Inc. Compuestos aminoheteroarílicos como inhibidores de proteín quinasas
RS52908B (en) 2003-03-10 2014-02-28 Takeda Gmbh NEW PROCEDURE FOR OBTAINING ROFLUMILAST
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20080280944A1 (en) * 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602005009257D1 (de) * 2004-12-17 2008-10-02 Pfizer Chroman-derivate als säurepumpenantagonisten
JP5383183B2 (ja) 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
EP1863811B1 (en) * 2005-03-21 2014-03-12 MEI Pharma, Inc. Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
EP1861095A1 (en) * 2005-03-24 2007-12-05 Glaxo Group Limited Derivatives of imidazo(1,2-a)pyridine useful as medicaments for treating gastrointestinal diseases
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
WO2007066187A2 (en) 2005-12-05 2007-06-14 Pfizer Products Inc. Method of treating abnormal cell growth
US8217057B2 (en) 2005-12-05 2012-07-10 Pfizer Inc. Polymorphs of a c-MET/HGFR inhibitor
KR20080108129A (ko) * 2006-03-17 2008-12-11 라퀄리아 파마 인코포레이티드 크로메인 유도체
EP2054036B1 (en) 2006-07-24 2019-12-18 Singh-Broemer and Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
GB2471619B (en) * 2008-03-31 2012-10-31 Council Scient Ind Res Method for the simultaneous preparation of 3-acetoxy-17-acetamdo-16-formyl-androst-5,16-diene and 3-acetoxy-2'-chloro-5-androsteno[17,6-B]pyridine
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
RU2403904C1 (ru) * 2009-02-26 2010-11-20 Федеральное государственное учреждение "Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Росздрава" Способ профилактики острых гастродуоденальных язв у больных колоректальным раком в раннем послеоперационном периоде
BRPI1013288A2 (pt) 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
EP3013345B1 (en) * 2013-06-25 2017-11-22 F. Hoffmann-La Roche AG Compounds for treating spinal muscular atrophy
KR102430072B1 (ko) 2013-12-16 2022-08-10 에이비에스 디벨롭먼트 원 인코포레이티드 P2x3 및/또는 p2x2/3 화합물 및 방법
MX367267B (es) * 2014-03-24 2019-08-12 Arqule Inc Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
CN111683976B (zh) 2018-02-05 2022-11-18 生物辐射实验室股份有限公司 具有阴离子交换-疏水混合模式配体的色谱树脂
MX2020010636A (es) 2018-04-10 2020-10-28 Bayer Ag Proceso para la produccion de acidos 2,6-dialquilfenilaceticos.
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
AU2020377451A1 (en) 2019-11-04 2022-05-26 Cinclus Pharma Holding AB Oral formulation of X842
MX2024005463A (es) 2021-11-05 2024-05-22 Cinclus Pharma Holding Ab Publ Polimorfos de la sal de mesilato de glurato de linaprazan.
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
CN120457131A (zh) 2023-01-11 2025-08-08 辛克鲁斯制药控股有限公司 (Publ) 戊二酸利那拉生酯的氢溴酸盐的多晶型物
WO2024149833A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the maleic acid salt of linaprazan glurate
WO2024161317A1 (ko) * 2023-02-01 2024-08-08 제일약품주식회사 약학적 제제, 이의 제조 방법, 및 정제용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107513D0 (en) * 1991-04-10 1991-05-29 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
EP1073656A1 (en) 2001-02-07
ID26819A (id) 2001-02-15
CZ20003981A3 (cs) 2001-03-14
DE69937076T2 (de) 2008-05-29
SA99200065B1 (ar) 2006-11-07
CN1165535C (zh) 2004-09-08
TWI250159B (en) 2006-03-01
DE69927803D1 (de) 2006-03-02
SA99200065A (ar) 2005-12-03
KR20010043133A (ko) 2001-05-25
HUP0102313A2 (hu) 2001-12-28
CN1307577A (zh) 2001-08-08
ATE312101T1 (de) 2005-12-15
SK14922000A3 (sk) 2001-06-11
EP1073657B1 (en) 2005-12-07
JP3692034B2 (ja) 2005-09-07
NO20005450L (no) 2000-12-22
EE200000626A (et) 2002-04-15
CZ293977B6 (cs) 2004-09-15
JP2002513025A (ja) 2002-05-08
HUP0102425A2 (hu) 2001-11-28
AU4300699A (en) 1999-11-16
KR20050121760A (ko) 2005-12-27
RU2235725C2 (ru) 2004-09-10
BR9909995B1 (pt) 2010-07-13
BR9909996A (pt) 2000-12-26
HK1033317A1 (en) 2001-08-24
JP2002513024A (ja) 2002-05-08
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
DE69937077T2 (de) 2008-05-29
HK1033457A1 (en) 2001-08-31
ID27530A (id) 2001-04-12
WO1999055706A1 (en) 1999-11-04
EP1491542A3 (en) 2005-01-05
EP1073656B1 (en) 2005-10-19
EE04676B1 (et) 2006-08-15
UA66846C2 (uk) 2004-06-15
CA2329921A1 (en) 1999-11-04
ES2252975T3 (es) 2006-05-16
NZ507638A (en) 2003-10-31
IS5683A (is) 2000-10-25
DE69937077D1 (de) 2007-10-18
RU2238271C2 (ru) 2004-10-20
KR100650472B1 (ko) 2006-11-28
NZ507639A (en) 2004-01-30
TR200102728T2 (tr) 2002-06-21
HUP0102313A3 (en) 2002-10-28
NO318203B1 (no) 2005-02-14
JP3883383B2 (ja) 2007-02-21
NO20005450D0 (no) 2000-10-27
US6313137B1 (en) 2001-11-06
EP1491543B1 (en) 2007-09-05
IL139297A (en) 2007-06-03
SK285768B6 (sk) 2007-07-06
AU769190B2 (en) 2004-01-22
CZ292567B6 (cs) 2003-10-15
SK14912000A3 (sk) 2001-06-11
CA2329922A1 (en) 1999-11-04
EP1491543A1 (en) 2004-12-29
KR20010043134A (ko) 2001-05-25
CN1174980C (zh) 2004-11-10
UA67769C2 (uk) 2004-07-15
HK1071139A1 (en) 2005-07-08
WO1999055705A1 (en) 1999-11-04
HK1036981A1 (en) 2002-01-25
DE69937076D1 (de) 2007-10-18
DE69927803T2 (de) 2006-07-06
KR100595805B1 (ko) 2006-07-03
SI1073656T1 (sl) 2006-02-28
BR9909995A (pt) 2000-12-26
HK1036984A1 (en) 2002-01-25
SE9801526D0 (sv) 1998-04-29
MY121389A (en) 2006-01-28
CA2329922C (en) 2006-04-11
CZ20003982A3 (cs) 2001-02-14
DE69928792D1 (de) 2006-01-12
DE69928792T2 (de) 2006-07-20
ATE372340T1 (de) 2007-09-15
DK1073656T3 (da) 2006-01-16
EP1073657A1 (en) 2001-02-07
EP1491542A2 (en) 2004-12-29
NO20005451L (no) 2000-12-27
MY121379A (en) 2006-01-28
PL343801A1 (en) 2001-09-10
AU4300799A (en) 1999-11-16
DK1073657T3 (da) 2006-03-13
IS5684A (is) 2000-10-25
PL195000B1 (pl) 2007-07-31
CN1306533A (zh) 2001-08-01
IL139200A (en) 2010-04-29
TR200003176T2 (tr) 2001-03-21
TR200102612T2 (tr) 2002-06-21
AR015768A1 (es) 2001-05-16
SA99200064B1 (ar) 2006-10-11
TR200003149T2 (tr) 2001-03-21
EE04916B1 (et) 2007-10-15
NO20005451D0 (no) 2000-10-27
PL343797A1 (en) 2001-09-10
HUP0102425A3 (en) 2002-12-28
NO317262B1 (no) 2004-09-27
KR100595806B1 (ko) 2006-07-03
ATE372339T1 (de) 2007-09-15
ZA200005797B (en) 2002-01-18
BR9909996B1 (pt) 2010-08-24
ES2249913T3 (es) 2006-04-01
US6313136B1 (en) 2001-11-06
WO1999055706A9 (en) 2000-03-16
ZA200005796B (en) 2002-01-18
AU769108B2 (en) 2004-01-15
TW490466B (en) 2002-06-11
ATE307130T1 (de) 2005-11-15
AR015769A1 (es) 2001-05-16
IL139200A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
IL139200A0 (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
PL345794A1 (en) Aminomethylcarboxylic acid derivatives
SI1129088T1 (sl) Kristalinična oblika (R)-2(((3-metil-4-(2,2,2-trifluoroetoksi)-2-piridinil)metil)sulfinil)- 1H-benzimidazola
EE9900367A (et) Ühendid maohappesekretsiooni inhibeerimiseks
PL354600A1 (en) Naphthyridine derivatives
SI1105391T1 (en) Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
HU9302741D0 (en) Gastric acid secretion inhibiting new pyrrolo[2,3-b]pyridine derivatives
HRP20000529B1 (en) Novel dihydroxyhexanoic acid derivatives
IL148031A0 (en) Torsemide polymorphs
AU1056302A (en) Polysubstituted imidazopyridines as gastric secretion inhibitors
IL131644A0 (en) Process for the preparation of nicotinic acid
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
GB9925457D0 (en) Gastric acid secretion
HU9900194D0 (en) Process for the preparation of pyridine dicarboxylate-derivatives
GB9705031D0 (en) 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
SI1073657T1 (sl) Imidazo piridinski derivati, ki inhibirajo izlocanje zelodcne kisline
IL128611A0 (en) Process for the preparation of substituted pyridines
SI1105390T1 (en) Imidazo(1,2-a)pyridine derivatives for the treatment of gastrointestinal diseases
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed